132.68
2.80%
+3.62
Pre-mercato:
131.775
-0.905
-0.68%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRNA Giù?
Forum
Previsione
Moderna Inc Borsa (MRNA) Ultime notizie
Could Novavax Become the Next Moderna?
The Motley Fool
Moderna Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Moderna's Coffee Break Science social media series brews up biopharma buzz - MM+M Online
MM+M Online
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks Investment Research
Moderna (NASDAQ:MRNA) Upgraded by Evercore ISI to Hold - Defense World
Defense World
Evercore ISI Initiates Coverage on Moderna (NASDAQ:MRNA) - Defense World
Defense World
Moderna Japan aiming for combined COVID-flu mRNA vaccine clinical trials this winter - MSN
MSN
The Operation Warp Speed Story Worsens By the Day - RealClearMarkets
RealClearMarkets
Moderna Inc. stock rises Wednesday, still underperforms market - MarketWatch
MarketWatch
Moderna Q1: A Promising Pipeline Is Undervalued (NASDAQ:MRNA) - Seeking Alpha
Seeking Alpha
Jim Cramer: This Industrial Company Is ‘Absolutely Terrific’, Recommends Buying Modine Manufacturing - Mo - Benzinga
Benzinga
Evercore ISI Group Initiates Coverage of Moderna (MRNA) with In-Line Recommendation - MSN
MSN
Moderna Japan aiming for combined COVID-flu mRNA vaccine clinical trials this winter - The Mainichi - The Mainichi
The Mainichi
Cramer's Lightning Round: 'I'm a believer' in Moderna - CNBC
CNBC
Moderna Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Teacher Retirement System of Texas Sells 10,124 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
MarketBeat
Moderna Stock Rebounds From Its RSV Fallout — Is It A Buy, Again? - Investor's Business Daily
Investor's Business Daily
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks Investment Research
Stock Market News for May 14, 2024
Zacks Investment Research
Apollon Wealth Management LLC Sells 3388 Shares of Moderna, Inc. (NASDAQ:MRNA) - Defense World
Defense World
Teacher Retirement System of Texas Trims Position in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Defense World
Is This a Setback for Moderna?
The Motley Fool
Natixis Advisors L.P. Has $2.45 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Defense World
Spire Wealth Management Cuts Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Defense World
As 'Roaring Kitty' Returns, Here Are 3 ETFs To Leverage The 2024 Meme Stock Wave
Benzinga
US FDA's Delay In Acting On Moderna RSV Vaccine Adds To Growing List of User Fee Goal Misses - Pink Sheet
Pink Sheet
Moderna Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks Investment Research
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks Investment Research
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine - Zacks Investment Research
Zacks Investment Research
Company News For May 13, 2024 - Yahoo Finance
Yahoo Finance
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know - Yahoo Finance
Yahoo Finance
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
The Motley Fool
Moderna to Present at Upcoming Conferences in May/June 2024 - Sacramento Bee
Sacramento Bee
2278 Shares in Moderna, Inc. (NASDAQ:MRNA) Acquired by Fisher Asset Management LLC - Defense World
Defense World
FDA delays decision on Moderna's RSV vaccine - pharmaphorum
pharmaphorum
U.S. inks $1.5 billion deal with Moderna for 100 million doses of COVID-19 vaccine - Yahoo Singapore News
Yahoo Singapore News
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
The Motley Fool
FDA review of Moderna's RSV vaccine delayed to late May - Investing.com Nigeria
Investing.com Nigeria
U.S. grants full approval to Moderna's COVID vaccine in adults - Yahoo Canada Shine On
Yahoo Canada Shine On
Moderna, Inc. (NASDAQ:MRNA) Director Sells $1,825,200.00 in Stock - MarketBeat
MarketBeat
Moderna Inc. stock underperforms Friday when compared to competitors - MarketWatch
MarketWatch
Moderna's RSV Vaccine Candidate Review Delayed — Precision Vaccinations News - Precision Vaccinations
Precision Vaccinations
Moderna, Inc. (NASDAQ:MRNA) Stake Boosted by Intrinsic Value Partners LLC - MarketBeat
MarketBeat
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? (CORRECTED)
Benzinga
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday?
Benzinga
FDA delays decision date for Moderna's RSV vaccine - The Business Journals
The Business Journals
Moderna: FDA postpones RSV vaccine approval - Yahoo Finance
Yahoo Finance
US drug regulator delaying decision on RSV vaccine approval, says Moderna - Business Standard
Business Standard
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline - Morningstar
Morningstar
Capitalizzazione:
|
Volume (24 ore):